Cannabis and Hemp Industry Investment News
What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE: LXRP-OTCQX: LXRP) CEO Chris Bunka joined Steve Darling from Proactiv...
Lexaria said the agreement does not contemplate the development of oral nicotine consumer products in North America Lexaria Bioscience Corp () () anno...
The bioscience company said it has applied for a P2020 research grant under the project name SkanABility for a proof-of-concept study of the biologica...
The company is offering more than 2.5 million shares in total at a price of C$0.51 per share Canntab is focused on the manufacturing and distribution ...
The distribution agreement with Cloud 9 Switzerland LLC will see it sell Innocan’s SHIR Beauty and Relief & Go lines in the two countries The deal...
Canntab had originally announced that Latowsky would be appointed to the board as executive chairman, however, the board of directors unanimously dete...
What are you searching for? viewInnoCan Pharma Innocan Pharma Corporation () CEO Iris Bincovich and Endless Sky CEO Travis George tells Proactive the ...
ESI will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its facility in Saskatchewan Innocan’s products include its R...
The company said its products have “successfully" passed safety assessment in accordance with European Union cosmetic regulation No 1223/2009 CEO Iris...
InnoCan is working on a revolutionary exosome-based technology that targets both central nervous system indications and COVID-19 coronavirus symptoms ...
What are you searching for? viewEXMceuticals CEO Jonathan Summers acquired 11.3 million shares by way of a private placement, representing around 16.4...
The study will evaluate blood pressure reduction in 24 pre- or mild hypertension patients, who will receive a 300 milligram dose of CBD with or withou...
The Vancouver-based firm closed a C$1,036,000 oversubscribed private placement consisting of nearly 5.2 million units priced at $0.20 EXMceuticals als...
The group believes a successful uplisting should provide significant benefits to its shareholders that include increased liquidity, a much larger audi...
What are you searching for? viewInnoCan Pharma Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news t...
What are you searching for? viewLexaria Bioscience Corp. Lexaria BioScience (OTCQX: LXRP- CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactiv...
The oral nicotine formulation demonstrated “acceptable” chemical and microbiological stability and saw no issues with throat irritation in oral pouch ...
The pain relief formulation contains a combination of Magnesium oil, Methyl salicylate, Menthol and CBD About 1.5 billion people worldwide suffer from...
Recipharm unites more than 30 facilities across 10 different countries offering pharmaceutical development and manufacturing services Exosomes, extrac...
The debt is being settled through the issuance of 335,570 common shares to a former service provider at $0.149 each The company focuses on the develop...
